Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trafficking protein particle complex subunit 11 (TRAPPC11) is a protein encoded by the TRAPPC11 gene in humans. It is a subunit of the TRAPP (transport protein particle) multisubunit tethering complex, which facilitates intracellular vesicle trafficking, specifically at early stages of endoplasmic reticulum (ER) to Golgi transport. TRAPPC11 plays a critical role in maintaining Golgi apparatus structure, protein glycosylation, and autophagy. Pathogenic variants in TRAPPC11 result in a spectrum of recessive diseases, most notably limb-girdle muscular dystrophy type 2S (LGMDR18/2S), as well as syndromic phenotypes featuring myopathy, intellectual disability, and liver/ocular involvement. TRAPPC11 does not constitute a direct therapeutic drug target, but its genetic and cellular functions are clinically significant in understanding syndromic muscular dystrophies and related disorders[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trafficking protein particle complex subunit 11 (TRAPPC11).